Parma, Italy

Alessandro Bertucci

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Universitéde Strasbourg. Active years: 2020.


 

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2020

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Alessandro Bertucci

Introduction

Alessandro Bertucci is a notable inventor based in Parma, Italy. He has made significant contributions to the field of bioactive macromolecules through his innovative research and patents. His work focuses on the development of advanced materials that can encapsulate and release bioactive substances effectively.

Latest Patents

One of his key patents is titled "Disintegratable core/shell silica particles for encapsulating and releasing bioactive macromolecules." This invention relates to the creation of disintegratable core/shell silica particles that encapsulate a bioactive macromolecule or a cluster of bioactive macromolecules in an active conformation. The patent outlines a method for producing these particles and discusses their various applications.

Career Highlights

Alessandro Bertucci is affiliated with the University of Strasbourg, where he continues to engage in research and development. His work has garnered attention for its potential applications in various fields, including pharmaceuticals and biotechnology. He holds 1 patent, showcasing his innovative approach to solving complex scientific challenges.

Collaborations

Throughout his career, Bertucci has collaborated with esteemed colleagues, including Luisa De Cola and Eko Adi Prasetyanto. These collaborations have enriched his research and expanded the impact of his inventions.

Conclusion

Alessandro Bertucci's contributions to the field of bioactive macromolecules highlight his innovative spirit and dedication to advancing scientific knowledge. His work continues to inspire future research and development in this important area.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…